Leuppi, Jörg D; Bridevaux, Pierre-Olivier; Charbonnier, Florian; Clarenbach, Christian; Duchna, Hans-Werner; Gianella, Pietro; Jochmann, Anja; Kern, Lukas; Meyer, Franca; Pavlov, Nikolay; Rothe, Thomas; Steurer-Stey, Claudia; Von Garnier, Christophe (2022). [Novelties in the Treatment of Asthma]. Revue médicale suisse, 18(787), pp. 1269-1274. Médecine & Hygiène 10.53738/REVMED.2022.18.787.1269
Full text not available from this repository. (Request a copy)For general practitioners there have been important novelties in the treatment of asthma due to recent modifications of the international guidelines from Global Initiative for Asthma (GINA). In Step 1, use of short-acting beta2-agonists (SABA) without concomitant inhaled corticosteroids (ICS) as controller is no longer recommended for lack of efficacy and safety reasons. Instead, low dose ICS-formoterol as needed is recommended. In Step 5, in patients with severe uncontrolled asthma GINA recommends targeted biologic therapies like interleukin antibodies. Asthma patients presenting simultaneously with symptoms of chronic obstructive pulmonary disease (COPD) should receive treatment containing ICS. Independent of the current corona pandemic, GINA recommendations stay in place.
Item Type: |
Journal Article (Further Contribution) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Gastro-intestinal, Liver and Lung Disorders (DMLL) > Clinic of Pneumology |
UniBE Contributor: |
Pavlov, Nikolay Assenov |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
1660-9379 |
Publisher: |
Médecine & Hygiène |
Language: |
French |
Submitter: |
Pubmed Import |
Date Deposited: |
24 Jun 2022 10:48 |
Last Modified: |
05 Dec 2022 16:21 |
Publisher DOI: |
10.53738/REVMED.2022.18.787.1269 |
PubMed ID: |
35735152 |
URI: |
https://boris.unibe.ch/id/eprint/170877 |
Actions (login required)
 |
Edit item |